| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/19/2000 | CN1242045A Immunotherapy and improved vaccines |
| 01/19/2000 | CN1242005A Process for producing imidazole derivatives |
| 01/19/2000 | CN1241440A Preparation of onychomycosis liquor |
| 01/19/2000 | CN1241426A Convalescence capsule for treating gonarrhea and its preparation process |
| 01/19/2000 | CN1241405A Oral linmerjing as one kind of powerful anti-bacterial medicine |
| 01/19/2000 | CN1048494C Process for preparing carbapenen and penem compounds and new compound involved in that process |
| 01/18/2000 | US6015913 Heating cocoa beans to loosen shell without roasting nib, winnowing nibs from shells, screw pressing nibs to produce cocoa butter and partially defatted cocoa solids |
| 01/18/2000 | US6015912 Treating arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease |
| 01/18/2000 | US6015883 Amino acid sequence of purified chemokine polypeptide; treatment of immune deficiency diseases, autoimmune diseases, allergies or asthma; anticarcinogenic/antiinflammatory/ antiarthritic agents |
| 01/18/2000 | US6015876 Treating medical and laboratory equipment and supplies, suspensions, solutions, blood, blood products, and tissues by contacting with viricidal protein, peptide, or conjugate |
| 01/18/2000 | US6015832 Methods of inactivating bacteria including bacterial spores |
| 01/18/2000 | US6015825 Triazole antifungal agents |
| 01/18/2000 | US6015820 4-Aryl-thio-pyridin-2(1H)-ones, medicines containing them and their uses in the treatment of illnesses linked to HIV |
| 01/18/2000 | US6015804 Method of using tetracycline compounds to enhance interleukin-10 production |
| 01/18/2000 | US6015799 Restricting the degree of substitution of the dextrin sulphate to a maximum of 2, |
| 01/18/2000 | US6015712 Antisense modulation of FADD expression |
| 01/18/2000 | US6015695 Immunoglobulins devoid of light chains |
| 01/18/2000 | US6015688 Transferrin receptor genes |
| 01/18/2000 | US6015669 Identification of genes |
| 01/18/2000 | US6015578 Trapidil for use in the therapy of syndrome that may be influenced by immunomodulators |
| 01/18/2000 | US6015566 Peptide composition generating an immune response against herpes virus |
| 01/18/2000 | US6015564 Polypeptides with fatty acid and steroids |
| 01/18/2000 | US6015560 Antibody recognizing endothelial cell ligand for leukocyte CR3 |
| 01/18/2000 | CA2168764C Novel quinolone carboxylic acid derivatives |
| 01/18/2000 | CA2035314C Triazole antifungal agents |
| 01/18/2000 | CA2006587C Membrane proteins and peptides of haemophilus influenzae type b |
| 01/13/2000 | WO2000001835A2 Targeted integration into chromosomes using retroviral vectors |
| 01/13/2000 | WO2000001730A1 Peptides based on the sequence of human lactoferrin and their use |
| 01/13/2000 | WO2000001715A1 Novel cyclosporin with improved activity profile |
| 01/13/2000 | WO2000001703A1 Process for the preparation of 3-cephem compounds |
| 01/13/2000 | WO2000001702A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | WO2000001701A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | WO2000001677A1 Piperazine derivatives inhibiting human immunodeficiency virus replication |
| 01/13/2000 | WO2000001427A1 Bone cement with antimicrobial peptides |
| 01/13/2000 | WO2000001409A2 Porcine circovirus and parvovirus vaccine |
| 01/13/2000 | WO2000001408A2 Haemophilus parasuis vaccine and diagnostic |
| 01/13/2000 | WO2000001400A1 Compositions comprising endotoxin neutralizing protein and derivatives and uses thereof |
| 01/13/2000 | WO2000001398A1 Anti-viral plant extract |
| 01/13/2000 | WO2000001382A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | WO2000001378A1 Methods and compositions for treatment of disorders associated with chlamydial and similar bacterial infection |
| 01/13/2000 | WO2000001349A2 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same |
| 01/13/2000 | WO2000001345A2 Use of an amphipathic compound for providing an adjuvant to a subunit vaccine |
| 01/13/2000 | WO2000001238A1 Methods for eradication of nanobacteria |
| 01/13/2000 | WO1999059617A3 Immunoregulator |
| 01/13/2000 | WO1999058540A3 1-galactose derivatives |
| 01/13/2000 | WO1999055312A3 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 01/13/2000 | WO1999053950A3 Live vaccines and methods of treatment therewith |
| 01/13/2000 | WO1999053047A3 Porcine adenovirus type 3 genome |
| 01/13/2000 | WO1998049177A8 Anti-viral pyrimidine nucleoside analogues |
| 01/13/2000 | DE19920966A1 alpha-Ketoamidderivate alpha-Ketoamidderivate |
| 01/13/2000 | CA2337059A1 Piperazine derivatives inhibiting human immunodeficiency virus replication |
| 01/13/2000 | CA2337048A1 Use of an amphipathic compound for providing an adjuvant to a subunit vaccine |
| 01/13/2000 | CA2336475A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | CA2336448A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | CA2336320A1 Haemophilus parasuis vaccine and diagnostic |
| 01/13/2000 | CA2336054A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | CA2336030A1 Bone cement with antimicrobial peptides |
| 01/12/2000 | EP0970693A1 Biologically active labdane or labdene derivatives from Cistus |
| 01/12/2000 | EP0970198A2 Novel compounds |
| 01/12/2000 | EP0970186A1 SpoOJ2 OF STAPHYLOCOCCUS AUREUS |
| 01/12/2000 | EP0970115A1 Viral peptides with structural homology to protein g of respiratory syncytial virus |
| 01/12/2000 | EP0970100A1 Benzimidazole derivatives |
| 01/12/2000 | EP0970098A1 Anthracycline glycosides |
| 01/12/2000 | EP0970087A1 A process for the preparation of a metal salt of clavulanic acid |
| 01/12/2000 | EP0970062A2 Pyrrolidine and thiazole derivatives with metallo-beta-lactamase inhibitory properties |
| 01/12/2000 | EP0970055A2 Hiv protease inhibitors |
| 01/12/2000 | EP0970046A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/12/2000 | EP0969869A2 Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders |
| 01/12/2000 | EP0969864A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
| 01/12/2000 | EP0969863A1 Viral defective interfering particles and uses thereof |
| 01/12/2000 | EP0969862A2 SYNTHETIC HIV $i(GAG) GENES |
| 01/12/2000 | EP0969858A1 RIBOSOME RECYCLING FACTOR (FRR) OF $i(STAPHYLOCOCCUS AUREUS) |
| 01/12/2000 | EP0969856A1 Hydrophilic binary systems for the administration of cyclosporine |
| 01/12/2000 | EP0969851A1 Immunomodulatory complex and use thereof in helicobacter diseases |
| 01/12/2000 | EP0969844A1 Administration of an injectable antibiotic in the ear of an animal |
| 01/12/2000 | EP0969824A1 Use of inhibitors of undecaprenol kinase to inhibit cell wall biosynthesis |
| 01/12/2000 | EP0969821A1 Pellets having a core coated with an antifungal and a polymer |
| 01/12/2000 | EP0969815A2 Pharmaceutical compositions |
| 01/12/2000 | EP0969814A1 Opthalmic non-irritating iodine medicament and method |
| 01/12/2000 | EP0639079B1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
| 01/12/2000 | EP0548234B1 Cloning of chicken anaemia dna |
| 01/12/2000 | CN1241193A Meningococcus vaccine comprising valence of BZ23 strain |
| 01/12/2000 | CN1241191A Counterparts of camptothecin, their application as medicine and pharmaceutical compositions contg. them |
| 01/12/2000 | CN1048242C 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid deriv. and its preparing process, and intermediate compound |
| 01/12/2000 | CN1048240C Process for preparing 7-substed-9-substed. amino-6-demethyl-6-deoxytetracyclines |
| 01/11/2000 | US6013837 Aromatic amides, method for preparing and compositions containing same, and use thereof as pesticides |
| 01/11/2000 | US6013781 Semaphorin gene family |
| 01/11/2000 | US6013778 Process for the preparation of azithromycin |
| 01/11/2000 | US6013647 Benzoxazinedione derivatives, method of producing them and uses thereof |
| 01/11/2000 | US6013639 G cap-stabilized oligonucleotides |
| 01/11/2000 | US6013634 Solid support matrices containing a toxin binding oligosaccharide |
| 01/11/2000 | US6013632 Administration of one or more of glutathione, its disulfide dimer, ascorbate-2-phosphate, or n-acetyl-l-cysteine, with or without antioxidants |
| 01/11/2000 | US6013631 Bactericidal/permeability-increasing protein (BPI) deletion analogs |
| 01/11/2000 | US6013627 Organic compounds |
| 01/11/2000 | US6013514 Nucleic acid sequence coding for a membrane protein; for treatment diagnosis, dectection, and prevention of infections |
| 01/11/2000 | US6013505 Polynucleotide sequence coding a polypeptide in vovolved in coiling deoxyribonucleic acids; for diagnosis and antibiotic development against bacterial infection |
| 01/11/2000 | US6013487 Chimeric RNA molecules generated by trans-splicing |
| 01/11/2000 | US6013476 DNA encoding tumor necrosis related receptor TR7 |
| 01/11/2000 | US6013463 Diagnostic test kit for detecting campylobacter infection; for diagnosis of peptic ulcer disease or gastrointestinal cancer |
| 01/11/2000 | US6013455 Polynucleotides which identify and encode protein kinase homologs, amino acid sequences encoding pkh; methods of pkh production with expression vectors; hybridizes under given conditions |